Trial Profile
Effects of bisoprolol transdermal patch for perioperative myocardial injury in patients undergoing non-cardiac surgery (Multi center Randomized Control Trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Hypertension; Myocardial disorders
- Focus Therapeutic Use
- Acronyms MAMACARI
- 12 Feb 2020 Results published in the Circulation Journal
- 18 Nov 2019 Primary endpoint (prevalence of PMI defined as postoperative hs-cTnT 0.014 ng/mL and relative hs-cTnT change of 20%) has not been met, according to presented at the American Heart Association Scientific Sessions 2019
- 18 Nov 2019 Results assessing efficacy of beta blocker patch versus oral used during operation for prevention of Perioperative myocardial injury in high risk patients were presented at the American Heart Association Scientific Sessions 2019